Edition:
United States

People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

49.80USD
22 Jul 2016
Change (% chg)

$0.83 (+1.69%)
Prev Close
$48.97
Open
$49.02
Day's High
$49.89
Day's Low
$48.56
Volume
467,779
Avg. Vol
1,188,256
52-wk High
$80.71
52-wk Low
$27.14

Stejbach, Mark 

Mr. Mark P. Stejbach is Senior Vice President, Chief Commercial Officer of Alkermes PLC. Prior to assuming his current position, Mr. Stejbach served at Tengion, Inc. from 2008 to 2012, most recently as its Chief Commercial Officer. He previously held senior positions at Merck and Biogen Idec Inc. and has over 25 years of experience in biotech and pharmaceutical marketing, sales, managed care and finance. Mr. Stejbach served on the charitable board of the Commonwealth National Fund from 2003 through 2011 and has served on the Advisory Board of the Center for Value-Based Insurance Design since 2009.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

10,448,400

Shane Cooke

4,646,970

James Frates

2,565,400

Gordon Pugh

1,965,720

Kathryn Biberstein

3,041,000

Elliot Ehrich

3,188,760
As Of  30 Dec 2014